NEXGEL, Inc (NXGL): Utang-utang marang kapitalisasi buku

Tandha merek NEXGEL Inc. (NXGL)

Leveraging advancements in polymer chemistry for wound healing, NEXGEL, Inc. has established a foundation for growth. The current balance sheet leverage ratio demonstrates financial maturity, with the metric standing at 1.59. The company's prospects are based on its proprietary electronic cross-linking of materials and the expansion of sales through strategic B2B partnerships with cosmetic brands.

NXGL (NEXGEL Inc) riwayat Utang marang nilai buku saka 04.07.2022 nganti 27.10.2026
Produk asli NEXGEL Inc

This indicator reflects the dynamics of the total liabilities-to-equity ratio, reacting promptly to changes in debt load. The metric measures financial stability by determining the balance between capital security and the efficiency of borrowed funds utilization. For NEXGEL, Inc., which focuses on organic growth and strategic acquisitions, this parameter confirms a conservative approach to financing. Analyzing the extent to which balance sheet capital covers debt obligations allows for the timely detection of stagnation risks resulting from the underutilization of financial leverage.

Karo sapa NEXGEL, Inc. saingan

ISRG - Utang-utang marang kapitalisasi buku|Rasio utang marang nilai buku danaher.com DHR|Utang-utang marang kapitalisasi buku BDX (Becton Dickinson)|STE - Utang-utang marang aset resik|WST (West Pharmaceutical Services Inc) - Utang-utang marang kapitalisasi buku|Baxter Healthcare (BAX) - Utang marang nilai buku|MASI (Masimo Corporation) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku STVN|Rasio utang marang kapitalisasi buku Teleflex (TFX)|Rasio utang marang kapitalisasi buku Merit Medical Systems, Inc. MMSI|Utang marang nilai buku Envista Holdings Corp|Rasio utang marang aset resik ICU Medical Inc. ICUI|Utang-utang marang kapitalisasi buku XRAY (DENTSPLY SIRONA Inc.)|LMAT: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku AtriCure|STAA (STAAR Surgical Co.) - Rasio utang marang nilai buku|NAGE: Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik ZimVie Corp (ZIMV)|Utang marang nilai buku AngioDynamics, Inc.|Utang marang modal buku CERS (cerus.com)|Rasio utang marang kapitalisasi buku Teknova|MGRM - Rasio utang marang aset resik|Sharps Tech - Utang marang nilai buku|INFU: Utang-utang marang kapitalisasi buku|UTMD (Utah Medical Products) - Rasio utang marang kapitalisasi buku|KORU Medical (KRMD) - Utang marang nilai buku|Utang-utang marang kapitalisasi buku NYXH (Nyxoah)|Utang-utang marang nilai buku MBOT|Rasio utang marang kapitalisasi buku Pro-Dex Corp PDEX|Rasio utang marang nilai buku Zentek Corp ZTEK|Utang marang nilai buku Elutia Inc. (ELUT)|milestonescientific.com - Utang marang modal buku|Rasio utang marang kapitalisasi buku RVP (Retractable Tech)|HBIO: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku Femasys Corp|Meihua Medical Technologies Co., Ltd. (MHUA) - Rasio utang marang nilai buku|Utang-utang marang kapitalisasi buku POAI (Predictive Oncology Inc)|Utang-utang marang nilai buku Callan JMB Corp (CJMB)|Utang marang nilai buku Atrion ATRI|Rasio utang marang nilai buku NeuroMetrix Inc (NURO)